Aspire Biopharma Holdings Inc

Research Aspire Biopharma Holdings Inc (ASBP) on Bullrun: market cap USD 7.95M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerASBP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.95M
• Financial periodFY2025
• RevenueUSD 6.20K
• Net income-USD 24.48M
• Gross margin-1.9%

Valuation Snapshot

latest market cap is USD 7.95M.

About Aspire Biopharma Holdings Inc

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product.

Frequently asked questions

What is Aspire Biopharma Holdings Inc's market cap?

Aspire Biopharma Holdings Inc's market capitalization is USD 7.95M.

What does Aspire Biopharma Holdings Inc do?

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.